SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lindsay M. Coe, Srinivasan Arjun Tekalur, Yutian Shu, Melissa J. Baumann, Laura R. McCabe, Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation, Journal of Cellular Physiology, 2015, 230, 8
  2. 2
    Panagiota Andreopoulou, Richard S. Bockman, Management of Postmenopausal Osteoporosis, Annual Review of Medicine, 2015, 66, 1, 329

    CrossRef

  3. 3
    Weng-Foung Huang, Li-Chuang Chang, Yu-Hsiang Kao, Yu-Wen Wen, Fei-Yuan Hsiao, Li-Ning Peng, Yi-Wen Tsai, Liang-Kung Chen, Prolonged risk of subtrochanteric and diaphyseal femur fractures after discontinuing alendronate treatment: A nationwide nested case-control study in Taiwan, Journal of Clinical Gerontology and Geriatrics, 2015, 6, 2, 54

    CrossRef

  4. 4
    Michael Pazianas, Se-min Kim, Tony Yuen, Li Sun, Sol Epstein, Mone Zaidi, Questioning the association between bisphosphonates and atypical femoral fractures, Annals of the New York Academy of Sciences, 2015, 1335, 1
  5. 5
    Z. Wang, M. M. Ward, L. Chan, T. Bhattacharyya, Adherence to oral bisphosphonates and the risk of subtrochanteric and femoral shaft fractures among female medicare beneficiaries, Osteoporosis International, 2014, 25, 8, 2109

    CrossRef

  6. 6
    Chia-Jung Hu, Jenn-Huei Renn, Shan-Wei Yang, Kai-Cheng Lin, Atypical Femoral Fractures in a Patient with Continuous Decreasing BMD after Only 1.5 Years of Bisphosphonate Treatment, Open Journal of Rheumatology and Autoimmune Diseases, 2014, 04, 01, 29

    CrossRef

  7. 7
    Matthew Rheinboldt, Derrick Harper, Michael Stone, Atypical femoral fractures in association with bisphosphonate therapy: a case series, Emergency Radiology, 2014, 21, 5, 557

    CrossRef

  8. You have free access to this content8
    Elizabeth Shane, David Burr, Bo Abrahamsen, Robert A Adler, Thomas D Brown, Angela M Cheung, Felicia Cosman, Jeffrey R Curtis, Richard Dell, David W Dempster, Peter R Ebeling, Thomas A Einhorn, Harry K Genant, Piet Geusens, Klaus Klaushofer, Joseph M Lane, Fergus McKiernan, Ross McKinney, Alvin Ng, Jeri Nieves, Regis O'Keefe, Socrates Papapoulos, Tet Sen Howe, Marjolein CH van der Meulen, Robert S Weinstein, Michael P Whyte, Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research, Journal of Bone and Mineral Research, 2014, 29, 1
  9. 9
    Jie Liu, Hong-xin Zhang, Xiong-xiong Lu, Jia-jia Hu, Lian-fu Deng, Bisphosphonates and Risk of Subtrochanteric, Femoral Shaft, and Atypical Femur Fracture: Sensitivity and Trim and Fill Studies, Genetic Testing and Molecular Biomarkers, 2014, 18, 2, 117

    CrossRef

  10. 10
    Angela G. Juby, Sean Crowther, Marilyn Cree, Identifying Atypical Femoral Fractures—A Retrospective Review, Calcified Tissue International, 2014, 95, 5, 405

    CrossRef

  11. 11
    E. Verron, J.M. Bouler, Is bisphosphonate therapy compromised by the emergence of adverse bone disorders?, Drug Discovery Today, 2014, 19, 3, 312

    CrossRef

  12. 12
    Alvin C. Ng, Meng Ai Png, David T. Chua, Joyce S. B. Koh, Tet Sen Howe, Review: Epidemiology and Pathophysiology of Atypical Femur Fractures, Current Osteoporosis Reports, 2014, 12, 1, 65

    CrossRef

  13. 13
    E. Suresh, M. Pazianas, B. Abrahamsen, Safety issues with bisphosphonate therapy for osteoporosis, Rheumatology, 2014, 53, 1, 19

    CrossRef

  14. 14
    Anas Saleh, Vishal V. Hegde, Anish G. Potty, Joseph M. Lane, Bisphosphonate Therapy and Atypical Fractures, Orthopedic Clinics of North America, 2013, 44, 2, 137

    CrossRef

  15. 15
    Lydia Gedmintas, Daniel H Solomon, Seoyoung C Kim, Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: A systematic review and meta-analysis, Journal of Bone and Mineral Research, 2013, 28, 8
  16. 16
    Constance Beaudouin-Bazire, Noémie Dalmas, Julie Bourgeois, Antoine Babinet, Philippe Anract, Christophe Chantelot, Frédéric Farizon, Florence Chopin, Karine Briot, Christian Roux, Bernard Cortet, Thierry Thomas, Fréquence réelle des fractures fémorales ordinaires et atypiques sous-trochantériennes et diaphysaires en France en se basant sur l’analyse des radiographies et des dossiers médicaux, Revue du Rhumatisme, 2013, 80, 2, 167

    CrossRef

  17. 17
    Roberto C Güerri-Fernández, Xavier Nogués, José M Quesada Gómez, Elisa Torres del Pliego, Lluís Puig, Natalia García-Giralt, Guy Yoskovitz, Leonardo Mellibovsky, Paul K Hansma, Adolfo Díez-Pérez, Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls, Journal of Bone and Mineral Research, 2013, 28, 1
  18. 18
    Constance Beaudouin-Bazire, Noémie Dalmas, Julie Bourgeois, Antoine Babinet, Philippe Anract, Christophe Chantelot, Frédéric Farizon, Florence Chopin, Karine Briot, Christian Roux, Bernard Cortet, Thierry Thomas, Real frequency of ordinary and atypical sub-trochanteric and diaphyseal fractures in France based on X-rays and medical file analysis, Joint Bone Spine, 2013, 80, 2, 201

    CrossRef

  19. 19
    Paul Kostenuik, Osteoporosis, 2013,

    CrossRef

  20. 20
    Elizabeth Shane, Sundeep Khosla, David Burr, Osteoporosis, 2013,

    CrossRef

  21. 21
    Eve Donnelly, Anas Saleh, Aasis Unnanuntana, Joseph M. Lane, Atypical femoral fractures, Current Opinion in Supportive and Palliative Care, 2012, 6, 3, 348

    CrossRef

  22. 22
    Bo Abrahamsen, Thomas A. Einhorn, Beyond a reasonable doubt? Bisphosphonates and atypical femur fractures, Bone, 2012, 50, 5, 1196

    CrossRef

  23. 23
    Bo Abrahamsen, Emma M. Clark, Disentangling the Emerging Evidence around Atypical Fractures, Current Rheumatology Reports, 2012, 14, 3, 212

    CrossRef

  24. 24
    Rozalia Dimitriou, Giorgio Maria Calori, Peter V Giannoudis, Improving patients’ outcomes after osteoporotic fractures, International Journal of Clinical Rheumatology, 2012, 7, 1, 109

    CrossRef

  25. 25
    M. Pazianas, B. Abrahamsen, Y. Wang, R. G. G. Russell, Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases, Osteoporosis International, 2012, 23, 12, 2873

    CrossRef

  26. 26
    M.F. Swiontkowski, Oral Bisphosphonates and Risk of Subtrochanteric or Diaphyseal Femur Fractures in a Population-Based Cohort, Yearbook of Orthopedics, 2012, 2012, 45

    CrossRef

  27. 27
    Milka Maravic, Agnès Ostertag, Martine Cohen-Solal, Subtrochanteric/femoral shaft Versus hip fractures: Incidences and identification of risk factors, Journal of Bone and Mineral Research, 2012, 27, 1
  28. 28
    Serge Ferrari, Ego Seeman, Philippe Clézardin, David Karasik, David G Little, Toshio Matsumoto, Clinical and basic research papers – July 2011, IBMS BoneKEy, 2011, 8, 7, 305

    CrossRef

  29. 29
    Maurice Audran, Bernard Cortet, Thierry Thomas, Que sait-on des fractures fémorales atypiques ? Entre progrès et inconnues, Revue du Rhumatisme, 2011, 78, 5, 423

    CrossRef

  30. 30
    Maurice Audran, Bernard Cortet, Thierry Thomas, What do we know about atypical femoral fractures? Insights and enigmas, Joint Bone Spine, 2011, 78, 6, 568

    CrossRef

  31. 31
    Kathryn Dahir, Brandon Perry, Shubhada Jagasia, Post-Transplantation Bone Disease: Prevalence, Monitoring, Prevention, and Management Guidelines,